Daniel Jasewicz, M.S., is CEO of Phenomics Health™, a precision medicine company pioneering AI-driven solutions to optimize drug therapy using pharmacogenomics, pharmacometabolomics, and real-world data. With over a decade of experience in biotech, clinical research, and program leadership, he has overseen multidisciplinary teams and strategic partnerships with leading institutions, including the University of Michigan. Previously at Regeneron and IQVIA Biotech, he contributed to advancing biologics from discovery through clinical trials. At Phenomics Health, he leads development of a foundation model that integrates multi-omic data to personalize medication decisions, reduce adverse drug events, and accelerate drug discovery. He holds an M.S. in Physiology with a focus on cardiovascular pharmacology and has authored peer-reviewed publications in cardiometabolic research. His leadership bridges science, technology, and healthcare innovation.